Intra-Cellular Therapies Inc
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Show More...
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 122.00 EUR
-
Last Updated 01-04-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.75 -1.56 -1.07 -2.91 -2.69 -2.12 -2.84 -2.68 -2.78 Dividends USD Payout Ratio % * Shares Mil 22.0 17.0 29.0 36.0 43.0 46.0 55.0 55.0 58.0 Book Value Per Share * EUR 3.74 10.64 8.72 4.9 5.64 3.66 5.94 Free Cash Flow Per Share * EUR -0.71 -2.08 -2.14 -1.63 -1.84 -2.0 Return on Assets % -69.88 -36.2 -34.07 -26.67 -22.73 -37.44 -48.56 -38.9 Financial Leverage (Average) 1.22 1.09 1.02 1.04 1.04 1.12 1.29 1.12 Return on Equity % -84.98 -40.34 -35.12 -27.34 -23.56 -40.18 -57.62 -44.59 Return on Invested Capital % -83.79 -40.59 -35.46 -27.75 -24.52 -42.03 -55.1 -43.03 Interest Coverage -84.57 -42.8 Current Ratio 5.6 12.41 77.15 36.86 33.02 9.79 6.36 14.83 Quick Ratio 5.49 12.29 75.87 36.48 32.68 9.57 6.18 14.49 Debt/Equity 0.1 0.05